AzTrials
AzTrials

DementiaPhase 2/3EVIDEM-EDNCT00866099

Dementia Early Recognition and Response in Primary Care

A Phase 2/3 study testing Educational Dementia training in people with Dementia, run by University College, London at 2 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to develop and test an educational intervention for dementia in primary care, combining timely diagnosis, psychosocial support around the period of diagnosis and management concordant with guidelines. Read more about this study

Who is it for?
Any age
Conditions the study is for
Dementia
What is being tested?
Educational Dementia training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
125 participants
Where
2 sitesUnited Kingdom
Study dates
Jul 2009to Sep 2012
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients with memory or other cognitive impairments suggestive of dementia syndrome
  • those with a formal diagnosis of dementia, of any type.

Who cannot join

  • Patients and carers who are already involved in concurrent research
  • If the key professional feels that an approach to the person with dementia or their carer would be inappropriate, for example the dementia is very severe, or that an approach may increase distress
  • and any other important reason that the key professional may have for why the person with dementia or their carer should not be contacted.

Trial locations and contacts

2 sites in 1 country.

Steve Iliffe, BScMBBSFRCGP contact

0044-207-830-2393

s.iliffe@pcps.ucl.ac.uk

United Kingdom2 sites, 2 recruiting
  • Department of Primary Care and Population Health

    London, England, NW3 2PF

    Jane Wilcock, MA(hons) MSc, +44(0)20 7830 2239 ext. 38370, j.wilcock@pcps.ucl.ac.uk

    Priya Jain, MSc, +44(0)20 7830 2239 ext. 38370, p.jain@pcps.ucl.ac.uk

    Recruiting
  • University College London

    London, Greater London, NW3 2PF

    Enrolling by invitation

Other trials in United Kingdom

About this study

Official title: Evidence-based Interventions In Dementia EVIDEM-ED: Early Recognition and Response in Primary Care

The purpose of this study is to develop and test an educational intervention for dementia in primary care, combining timely diagnosis, psychosocial support around the period of diagnosis and management concordant with guidelines.

Read the detailed description

Dementia presents many challenges for primary care. Early diagnosis is important as this allows those with dementia and their family care networks to engage with support services and plan for the future. These actions can relieve the significant psychological distress that people with dementia and close supporters may experience , and provide knowledge about the availability of medical and psycho-social support that can improved functioning and morale

The main efforts to improve the identification and diagnosis of dementia should logically be targeted at primary care as this is the first point of contact for most individuals and their carers when faced with experiences of 'ill health'. There is, however, evidence that dementia remains under-detected and sub-optimally managed in general practice . An educational intervention that could enhance clinical practice, improving the skills of practitioners in the recognition of and response to dementia syndromes, could therefore be beneficial to people with dementia and their families, and potentially to health and social services.

Conditions
Dementia
Being tested
Educational Dementia training
Keywords
Dementia, primary care, early diagnosis, psychosocial interventions, cholinesterase inhibitors
Medical subject headings
Dementia, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Educational Dementia trainingOther

    Tailored learning activities on dementia, over a three-month period and will be given an electronic training manual (based on Microsoft packages) which they can run in the background during and after consultations with people with known or suspected dementia syndrome and face-to- face individualised workshop sessions.

    Tailoring of the education programme is carried out in a three step process: 1) an educational needs analysis is carried our using a standard checklist to identify aspects of dementia care which the practice perceives as problematic for them; 2) a prescription for education is then written to address shortcomings; 3) the best forms of learning are then identified.

Study groups in NCT00866099
Study groupRoleWhat they receive
"Normal Care"No interventionPrimary care practices randomly allocated will be given a summary of the NICE/SCIE dementia guidelines (2006) and offered workshop training and software at the end of the study.
TrainingExperimentalPractices randomly allocated to the intervention arm will be asked to participate in tailored learning activities on dementia, over a three-month period and will be given an electronic training manual (based on Microsoft packages) which they can run in the background during and after consultations with people with known or suspected dementia syndrome and face-to- face individualised workshop sessions.
Receives: Other: Educational Dementia training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. An increase in the proportion of patients with dementia receiving two dementia reviews per year, from 20% to 50%

    Measured: twelve month follow up

Secondary outcomes (7)
  1. quality of life, met and unmet need in carers and/or people with dementia

    Measured: twelve month follow up

  2. documented concordance with intervention recommendations on recording disclosure decisions & consequences

    Measured: twelve month follow up

  3. documented concordance with screening for depression

    Measured: twelve month follow up

  4. documented concordance with referral to social services

    Measured: twelve month follow up

  5. documented concordance with informing people with dementia and their carers about relevant local voluntary organisations

    Measured: twelve month follow up

  6. documented concordance with provision of legal information

    Measured: twelve month follow up

  7. documented concordance with shared management of cholinesterase inhibitor medication

    Measured: twelve month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2009 (estimated)
  2. Study startJul 2009
  3. Primary completionMay 2011 (estimated)
  4. Study completionSep 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
125 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00866099
Sponsor's protocol ID
FIS No: 49287
Other IDs
Award Code: GZFP
Acronym
EVIDEM-ED
Status last verified
Mar 2009
First submitted
19 Mar 2009
Last updated
19 Apr 2010
Results posted
No
Data monitoring committee
Yes

Publications

  • Wilcock J, Iliffe S, Griffin M, Jain P, Thune-Boyle I, Lefford F, Rapp D. Tailored educational intervention for primary care to improve the management of dementia: the EVIDEM-ED cluster randomized controlled trial. Trials. 2013 Nov 20;14:397. doi: 10.1186/1745-6215-14-397.

    PubMed 24257429
  • Iliffe S, Wilcock J, Griffin M, Jain P, Thune-Boyle I, Koch T, Lefford F. Evidence-based interventions in dementia: A pragmatic cluster-randomised trial of an educational intervention to promote earlier recognition and response to dementia in primary care (EVIDEM-ED). Trials. 2010 Feb 10;11:13. doi: 10.1186/1745-6215-11-13.

    PubMed 20146803

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Educational Dementia training in people with Dementia, run by University College, London at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Apr 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Steve Iliffe, BScMBBSFRCGP (0044-207-830-2393, s.iliffe@pcps.ucl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

An increase in the proportion of patients with dementia receiving two dementia reviews per year, from 20% to 50% (time frame: twelve month follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00866099, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in